Welcome to the 8th Microbiome Movement - Drug Development Summit
Be a part of the dynamic and critical field of microbiome drug development. Discover how drug developers are advancing their understanding of the role of the microbiome in disease and harnessing functionally relevant microbes for live biotherapeutic approaches.
With cutting-edge science, preclinical and clinical trial data, the 8th Microbiome Movement Drug Development Summit brings together pioneering drug developers and technology enablers to move the needle forward on microbial-based drug development innovation and healthcare industry adoption.
Explore critical areas of research, propel your business forward, and network with industry leaders through interactive sessions such as discussion-based workshops, roundtables, panel discussions, Q&As, and speed networking. With three tracks - Discovery, Pre-clinical & Translation, and Clinical & Manufacturing - discover innovative new content for 2023 from leveraging the fungal and viral components of the microbiome, tuning the microbiome using bacterial engineering, exploring medical foods, and securing capital to scale your biotech business.
Don't miss the opportunity to launch ground-breaking therapies into the market and be a part of this exciting time in microbiome drug development.
World-Class Speaker Faculty Includes:
Associate Director - Chemistry, Manufacturing, Control, Operations & Strategic Planning
Vedanta Biosciences Inc
Vice President - Biology
Associate Fellow - Research
Assistant Professor of Medicine
Stanford University School of Medicine
Vice President, Head of Preclinical Research and Development
Axial Therapeutics, Inc.
Professor & CEO
Postech Pohang University Of Science & Technology
Vice President - Technical Operations